Expression of pigment epithelium-derived factor in bladder tumour is correlated with interleukin-8 yet not with interleukin-1α

Abstract

Pigment epithelium-derived factor (PEDF) is an antiangiogenic factor which is effective in tumour inhibition in a variety of tumours and has not yet been studied in bladder tumour before. In this study the expression of PEDF, interleukin-1α (IL-1α) and -8 (IL-8) in bladder tumours was investigated. Immunohistochemistry was performed on 64 bladder tumour and 23 normal uroepithelium samples. Expression change of the factors was compared with clinicopathological parameters. Correlations between PEDF, IL-1α and IL-8 were analyzed. None of the factors was in relation to gender, tumour occurrence, and size or onset pattern. PEDF (P=0.014) and IL-1α (P=0.049) expression was down-regulated with grade progression. PEDF expression was lower in normal uroepithelium than in papillary urothelial neoplasm of low malignant potential (PUNLMP) (P=0.000) and carcinoma (P=0.009) whilst IL-1α (P=0.000 and P=0.000 respectively) and IL-8 (P=0.000 and P=0.023 respectively) expression was higher in the same grouping. PEDF expression had a negative correlation with IL-8 in PUNLMP (P=0.049, r=−0.578) as well as in tumour grouping (P=0.033, r=−0.276). Deranged expressional change of PEDF, IL-1α and IL-8 could be in relation to loss of differentiation from normal uroepithelium to papillary lesion and eventually to carcinoma.

Keywords

angiogenesis / bladder tumour / interleukin-1α / interleukin-8 / pigment epithelium-derived factor

References

[1] BergersG., BenjaminL.E.. Tumorigenesis and the angiogenic switch. Nat Rev Cancer, 2003, 3(6): 401-410

[2] American Cancer Society. Cancer facts and figures. Vol. 2005. Washington (DC), 2005.

[3] FerleyJ., BrayF., PisaniP., et al.. . Globalcan 2000: Cancer incidence, mortality and prevalence worldwide, version 1.0 LARC Cancer Base No. 5, 2001, Lyon, IARC Press

[4] MaJ., SawaiH., MatsuoY., et al.. Interleukin-1α enhances angiogenesis and is associated with liver metastatic potential in human gastric cancer cell lines. J Surg Res, 2008, 148(2): 197-204

[5] TachibanaM., MiyakawaA., NakashimaJ., et al.. Constitutive production of multiple cytokines and a human chorionic gonadotrophin beta-subunit by a human bladder cancer cell line (KU-19-19): possible demonstration of totipotential differentiation. Br J Cancer, 1997, 76(2): 163-174

[6] InoueK., SlatonJ.W., KimS.J., et al.. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. Cancer Res, 2000, 60(8): 2290-2299

[7] GuanM., JiangH., XuC., et al.. Adenovirus-mediated PEDF expression inhibits prostate cancer cell growth and results in augmented expression of PAI-2. Cancer Biol Ther, 2007, 6(3): 419-425

[8] ZhangT., GuanM., XuC., et al.. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo. Life Sci, 2007, 81(16): 1256-1263

[9] ApteR.N., DotanS., ElkabetsM., et al.. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev, 2006, 25(3): 387-408

[10] KitadaiY., TakahashiY., HarumaK., et al.. Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. Br J Cancer, 1999, 81(4): 647-653

[11] Feng C, Ding Q, Zhang Y, et al. Pigment epithelium-derived factor expression is downregulated in bladder tumors and correlates with vascular endothelial growth factor and matrix metalloproteinase-9. Int Urol Nephrol, 2010,DOI 10.1007/s11255-010-9834-4

[12] EbleJ.N., SauterG., EpsteinJ.I., et al.. . World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs, 2004, Lyon, IARC Press

[13] RosaiJ.. . Rosai and Ackerman’s Surgical Pathology, 2004, 1: 1317-1359

[14] IoachimE., MichaelM.C., SalmasM., et al.. Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components. BMC Cancer, 2006, 6: 140-147

[15] EkE.T., DassC.R., ChoongP.F.. PEDF: a potential molecular therapeutic target with multiple anti-cancer activities. Trends Mol Med, 2006, 12: 497-502

[16] FilleurS., VolzK., NeliusT., et al.. Two functional epitopes of pigment epithelial derived factor block angiogenesis and induce differentiation in prostate cancer. Cancer Res, 2005, 65(12): 5144-5152

[17] CrawfordS.E., StellmachV., RanalliM., et al.. Pigment epitheliumderived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity. J Cell Sci, 2001, 114(Pt24): 4421-4428

[18] Tombran-TinkJ., BarnsC.J.. PEDF: a multifaceted neurotrophic factor. Nat Rev Neurosci, 2003, 4(8): 628-636

[19] VoronovE., ShouvalD.S., KrelinY., et al.. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA, 2003, 100(5): 2645-2650

[20] LafrenieR.M., GalloS., PodorT.J., et al.. The relative role of vitronectin receptor, E-selectin and α4β1 in cancer cell adhesion to interleukin-1-treated endothrlial cells. Eur J Cancer, 1994, 30(14): 2151-2158

[21] LauriD., NeerdhamL., Martin-PaduraI., et al.. Tumor cell adhesion to endothelial cells: Endothelial leukocyte adhesion molecule-1 as an inducible adhesive receptor specific for colon carcinoma cells. J Natl Cancer Inst, 1991, 83(18): 1321-1324

[22] MackayA.R., BallinM., PelinaM.D., et al.. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell line. Invasion Metast, 1991, 12(3–4): 168-184

[23] Tran-ThangC., KruithofE., LahmH., et al.. Modulation of the plasminogen activation system by inflammatory cytokines in human colon carcinoma cells. Br J Cancer, 1996, 74(6): 846-852

[24] TomimatsuS., IchikuraT., MochizukiH.. Significant correlation between expression of Interkin-1α and liver metastasis in gastric cancer. Cancer, 2001, 91(7): 1272-1276

[25] SeddighzadehM., LarssonP., UlfgrenA.C., et al.. Low IL-1alpha expression in bladder cancer tissue and survival. Eur Urol, 2003, 43(4): 362-368

[26] SeddighzadehM., SteineckG., JanssonO., et al.. Low interleukin1alpha messenger RNA levels predict decreased overall survival time of patients with urinary bladder carcinoma. Br J Cancer, 2001, 84(3): 329-334

[27] ChikazawaM., InoueK., FukataS., et al.. Expression of angiogenesis-related genes regulates different steps in the process of tumor growth and metastasis in Human urothelial cell carcinoma of the urinary bladder. Pathobiology, 2008, 75(6): 335-345

[28] KoçakH., Oner-IyidoğanY., KoçakT., et al.. Determination of diagnostic and prognostic values of urinary interleukin-8, tumor necrosis factor-alpha, and leukocyte arylsulfatase-A activity in patients with bladder cancer. Clin Biochem, 2004, 37(8): 673-678

[29] IzawaJ.I., SlatonJ.W., KedarD., et al.. Differential expression of progression related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder. Oncol Rep, 2001, 8(1): 9-15